HOT NEWS
AstraZeneca
AstraZenecaAstraZeneca is a major international healthcare business engaged in research, development, manufacturing and marketing of prescription pharmaceuticals and supplier for healthcare services. AstraZeneca is one of the world's leading pharmaceutical companies with healthcare sales of US $29.55 billion and is a leader in gastrointestinal, cardiovascular, neuroscience, respiratory, oncology and infection product sales. AstraZeneca is listed in the Dow Jones Sustainability Index (Global) as well as the FTSE4Good Index. For more information visit www.astrazeneca.com.

AstraZeneca RSS Channel

Title Filter     Display # 
# Article Title Hits
1 European Commission Issues Positive Decision for Approval of Seroquel XR 168
2 Genetic substudy shows fewer major cardiovascular events with ticagrelor (BRILINTA) 520
3 AstraZeneca and MRC Technology Form Strategic Alliance in Discovery Research 723
4 AstraZeneca Submits Marketing Authorisation Application To European Union For Cardiovascular Drug Axanum 1001
5 Seroquel XR Recommended For Approval In EU as an Add-On Treatment Of Major Depressive Disorder 942
6 AstraZeneca Fourth Quarter and Full Year Results 2009 1201
7 AstraZeneca to Acquire Infection Research Company Novexel 1150
8 AstraZeneca PLC Third Quarter & Nine Months Results 2009 940
9 AstraZeneca withdraws regulatory submissions for Zactima (vandetanib) 1123
10 AstraZeneca Submits Marketing Authorisation Application to European Union for VIMOVO™ 1877
11 ONGLYZA (saxagliptin) Receives Marketing Authorisation in Europe for the Treatment of Type 2 Diabete 1332
12 Phase III Head to Head Trial Showed Ticagrelor Reduced Cardiovascular Death and Heart Attacks 1363
13 IRESSA (Gefitinib) Receives Marketing Authorisation in Europe 1256
14 ONGLYZA (saxagliptin) Receives Positive Opinion in Europe for the Treatment of Type 2 Diabetes 1324
15 AstraZeneca and Abbott Extend Relationship to Include Co-Promotion of Trilipix 867
16 AstraZeneca and Merck & Co., Inc. Form Pioneering Collaboration 889
17 AstraZeneca Announces Top Line Results From Pivotal Phase III Study for BRILINTA 1030
18 IRESSA (Gefitinib) Recommended for Approval for the Treatment of Non-Small Cell Lung Cancer in Europe 908
19 AstraZeneca PLC Fourth Quarter and Full Year Results 2008 881
20 MedImmune's Application for Intranasal Vaccine to Prevent Seasonal Influenza 1034
 
  • «
  •  Start 
  •  Prev 
  •  1 
  •  2 
  •  Next 
  •  End 
  • »
Page 1 of 2
Bookmark and Share